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Abstract
Background: Acute exacerbations of asthma are common in children. Multiple asthma
severity scores exist, but current emergency department (ED) use of severity scores is
not known.
Methods: A systematic review was undertaken to identify the parameters collected
in pediatric asthma severity scores. A survey of Paediatric Emergency Research in the
United Kingdom and Ireland (PERUKI) sites was undertaken to ascertain routinely col-
lected asthma data and information about severity scores. Included studies examined
severity of asthma exacerbation in children 5–18 years of age with extractable severity
parameters.
Results: Sixteen articles were eligible, containing 17 asthma severity scores. The sever-
ity scores assessed combinations of 15 different parameters (median, 6; range, 2–8).
The most common parameters considered were expiratory wheeze (15/17), inspira-
torywheeze (13/17), respiratory rate (10/17), and general accessorymuscle use (9/17).
Fifty-ninePERUKI centers responded to thequestionnaire. Twenty centers (33.1%) cur-
rently assess severity, but fewuse a published score. Themost commonly recorded rou-
tine data required for severity scores were oxygen saturations (59/59, 100%), heart
rate, and respiratory rate (58/59, 98.3% for both). Among well-validated scores like
the Pulmonary Index Score (PIS), Pediatric Asthma Severity Score (PASS), Childhood
Asthma Score (CAS), and the Pediatric Respiratory Assessment Measure (PRAM), only
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6/59 (10.2%), 3/59 (5.1%), 1/59 (1.7%), and 0 (0%) of units respectively routinely collect
the data required to calculate them.
Conclusion: Standardized published pediatric asthma severity scores are infrequently
used. Improved routine data collection focusing on the key parameters common tomul-
tiple scores could improve this, facilitating research and audit of pediatric acute asthma.
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1 INTRODUCTION
Asthma is one of the most common childhood diseases, affecting chil-
dren of all ages.1 Currently, there are approximately 1.1 million chil-
dren and young people affected by asthma in the United Kingdom.1
An exacerbation of asthma can vary in severity from a mild cough
and wheeze, to severe breathlessness that can be life-threatening.2
Exacerbations are a common reason for attendance at an emergency
department.3,4 In the last few years, there has been an increase in
UK pediatric asthma admission rates4,5; however, the reasons for this
increase are not fully understood.
Within theUnitedKingdom, there is an inequality in the distribution
of asthma prevalence and severity in children and young people, with
those from more deprived backgrounds suffering from increased fre-
quency and severity of disease.6,7 Around the country, there is 25-fold
variation in the pediatric asthma admission rates.7 Local authorities in
the North West of England have some of the highest rates of emer-
gency admissions for childhood asthma in the United Kingdom.8 There
may be different factors that have influenced this such as entrenched
inequality, access to healthcare, inappropriate admission, or under-
treatment of asthma. However, to fully comprehend the reason, an
understanding of the severity of asthma patients who present to EDs
needs to be included.
ED staff routinely assess asthma severitywhen seeing a child, but to
facilitate comparisons within and between units, and for research pur-
poses, scoring systemshave beendesigned to provide objective assess-
ments of how unwell individuals are. Each severity score assesses a
series of different parameters that alter in an acute asthma attack.
There is no single clinical sign that indicates the degree of exacerba-
tion, rather a collection of different symptoms and signs that point to
the severity.9 Tools to help assess the severity of asthma can provide
additional information regarding need for hospitalization or safety of
discharge. Historically, failure to assess severity was considered a fac-
tor that contributed tomortality.10
The current British Thoracic Society/Scottish IntercollegiateGuide-
lineNetwork (BTS/SIGN) guidelines2 categorize the severity of asthma
exacerbations into 3 main domains: moderate, severe, and life threat-
ening. Each domain contains different parameters that contribute to
degree of severity. Although this scoring system can be used to assess
overall severity at presentation, it does not numerically quantify sever-
ity, thus limiting its use in audit or research.
Current practice with regard to collection of data relating to, and
use of, pediatric asthma severity scores across the United Kingdom
and Ireland is not known. The Paediatric Emergency Research in the
United Kingdom and Ireland (PERUKI) group11 collaboratively under-
take pediatric emergency medicine research to improve care of sick
and injured children. This group is optimally placed across the United
Kingdom and Ireland to assess current practice.
The aimof this study is therefore to identify and extract the parame-
ters used in pediatric asthma severity scores. Thedatawill thenbeused
in a survey to assess current practicewith regard to data collection and
use of asthma severity in pediatric populations attending ED in the UK
and Ireland.
2 METHODOLOGY
2.1 Study design and setting
To undertake a systematic review of studies that assessed the sever-
ity of asthma exacerbations in the pediatric population, defined as chil-
dren and young people 5 to 18 years of age, was conducted.
2.2 Information sources and search strategy
Electronic databases, MEDLINE, CINAHL, and Web of Science were
searched up to December 2017 to identify relevant studies. There
were no date or language restrictions, the search terms used were
based upon 3 main terms; “asthma,” “pediatric,” and “severity score.”
See Supporting Information File S1 for full list of search terms.
2.3 Inclusion criteria and study selection
The term “severity score,” defined any dyspnea score that was devel-
oped to assess the severity of asthma exacerbations, comprises at least
2 different parameters. The “severity score” must have had a numeric
value associated with each measured parameter to allow variation in
the severity to be assessed.
Articles that described or used a severity score that could be used
tomeasure asthma exacerbations, in patients from5 to 18 years of age,
CHACKO ET AL. 3
were included. Articles that assessed dyspnea in relation to other con-
ditions such as bronchiolitis and rhinitis and articles that used a pre-
dictive score (looked at the need for hospitalization) were excluded
(see Supporting Information File S2 for inclusion and exclusion crite-
ria). Additional papers were located through the analysis of included
full-text screened papers by examining their references to see if addi-
tional studies may be eligible for inclusion.
2.4 Data extraction
Reviewers (JCandDH) independently screened the titles andabstracts
using the pre-specified criteria; full-texts of eligible articles were then
reviewed to assess eligibility of inclusion. Disagreements on the eligi-
bility of articles were resolved by consensus. Data were extracted into
a pre-defined table.
THE BOTTOMLINE
There are many published asthma severity scores for chil-
dren and young people attending hospital. This study exam-
ined the factors used to create these scores, the current use
of the scores, andUKemergencydepartment preferences for
such scores, to facilitate future data collection and compara-
tive research between the scoring systems.
2.5 Study outcomes
The pre-specified primary outcome were the parameters used to
generate each asthma severity score. Secondary outcomes were the
number of severity scores that used each specific parameter, and
the number of children that each severity score was scored against.
F IGURE 1 PRISMA flow diagram showing studies identified and included in the systematic review
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TABLE 2 Parameters recorded at each site
Parameter recorded
Percentages of
hospital sites that
recorded
parameter (%)
Number of
centers that
recorded
parameter
(out of 59)
02 saturation 100.0 59
Heart rate 98.3 58
Respiratory rate 98.3 58
General accessorymuscle
use/increasedwork of
breathing
64.4 38
Recession 55.9 33
Breath sounds 52.5 31
Tachypnea 52.5 31
Expiratory wheeze 49.2 29
Cerebral function/mental
status
47.5 28
Wheeze audible without
stethoscope
32.2 19
Inspiratory wheeze 25.4 15
Dyspnea 23.7 14
Substernal/subcostal/
intercostal recession
18.6 11
Suprasternal muscle/SCM
retraction
16.9 10
Inhalation-exhalation
ratio/prolonged expiratory
phase
5.1 3
Scalenemuscle retraction 3.4 2
Supraclavicular contraction 1.7 1
Because this study did not involve the synthesis of outcome of new
data, the methodological quality of the included studies were not
conducted because it was unnecessary.
2.5.1 Survey of UK practice among PERUKI sites
This multi-center cross-sectional online survey was delivered using
SurveyMonkey (https://www.surveymonkey.com/) betweenDecember
19, 2018 and January 30, 2019 across Paediatric Emergency Research
in theUnitedKingdom& Ireland (PERUKI)12; 1 nominated clinician per
site was asked to respond. The survey was developed iteratively by
the study team based feedback from pilot testing. The questionnaire
is available in Supplementary File 3. Regular reminders were sent from
the PERUKI team to improve response rate.
3 RESULTS
A total of 1574 studies were identified, with an additional 13 studies
obtained through additional sources. After removing duplicates, 1007
articles were screened with 36 articles undergoing full-text screening.
Of the 36 articles, 20 were excluded resulting in 16 eligible studies.
Supporting Information File S4 states reasons for exclusion of full-text
articles. The search strategy is summarized in Figure 1.
Our systematic review identified 17 different asthma severity
scores. Within the severity scores there were a total of 15 different
parameters measured (Table 1). Severity scores assessed a median of
6 parameters (range, 4–8).
The most common symptoms and/or signs measured among the
severity scores were “accessory muscle use or retraction or increased
workofbreathing” (Table1).Different scores requiredvariationsof this
symptom to be recorded, with “general assessment of accessory mus-
cle use or increased work of breathing” required in 53% (9/17) of the
severity scores, “Intercostal/Substernal/Subcostal recession” in 35%
(6/17), whereas “suprasternal/sternocleidomastoid retraction” use is
recorded in 29% (5/17). Only 2 severity scores included the use of sca-
lenemuscle retraction in their assessment.
The second most commonly assessed symptom/sign used in the
severity scoreswaswheeze, required in 88% (15/17) of severity scores.
Expiratory wheeze was used in 15/17 (88%) of severity scores, 13/17
(76%) included inspiratory wheeze, 7/17 (47%) included wheeze audi-
ble without a stethoscope.
Themean number of participants per study describing each severity
score was 239 (range, 30–1221). In 65% (11/17) of manuscripts, there
were fewer than 100 participants.
3.1 PERUKI site survey
There were 59 PERUKI sites that responded to the survey from a total
of 63. Responses were from consultants (53/59), nurses (3/59), and
other (3/59). The responses from each center were provided by the
lead clinician or a single delegate responsible for working with the
PERUKI team.
From the 15 parameters in the assessment scores, themedian num-
ber of these parameters collected by the PERUKI sites was 7 (range, 3–
14) (Table 2). The most commonly reported signs and symptoms from
PERUKI sites were O2 saturations (59/59), with 58/59 sites record-
ing heart rate and respiratory rate. Supraclavicular contraction was
recorded as being always captured at 1 hospital site.
Using their routinely collected data, Table 3 shows which sever-
ity scores could currently be used in each center. Previously pub-
lished validation for the scores are also noted in the table, based on a
study that compared the validity, reliability, and use of clinical scores
that assessed dyspnea.29 This systematic review published by Bekhof
et al29 showed that many of the severity scores had not been suffi-
ciently validated to be clinically significant in this cohort of children.
The severity scoreswere rated using the following system: positive (+),
intermediate (±), negative (−), unclear (?), or no information (0). The
sum of the positive-rated criteria is shown in Table 3 for the severity
scores analyzed in the systematic review.
Of the 59 PERUKI sites that responded, 33.90% (20/59) stated that
they used a severity scoring system in their EDs, with 11 sites saying
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TABLE 3 PERUKI site and severity score with validity scores
Severity score
PERUKI sites who
collect full dataset
Number of PERUKI
sites compared to all
PERUKI sites (%)
Average additional
parameters required
per site to complete
severity score Validity score29
ASS15 8 13.6 2.3 4
CAES217 7 11.9 2.5 4
PIS24 6 10.2 3.3 5
MPIS13 3 5.1 3.0 4
PASS21 3 5.1 2.8 5
RA28 2 3.4 3.8 4
PS27 2 3.4 2.1 2
CS26 1 1.7 3.9 3
CAS16 1 1.7 2.7 5
PRAM23 0 0.0 4.2 5
RAD25 0 0.0 3.2 4
their scoring system was based on the BTS/SIGN guidelines. Within
the sites, 18 used electronic record attendances, 17 via paper, and
24 recorded asthma attendances with a combination of both paper
and electronic. It is unclear if the sites have asthma assessments tem-
plates or required fields in their documentation, because this was not
examined.
The severity scores ASS, ASS2, and ASS-adj all had the highest per-
centage of complete collection among the PERUKI sites, with 8 sites
(13.6%) reporting they always collected the required parameters. Of
the 17 severity scores found among the systematic review, 3 sever-
ity scores (Koumbourlis, PRAM, and RAD) had no PERUKI sites that
always collected the required parameters.
Of the 17 severity scores, 11 had validity scores associated. Among
the well-validated scores like the Pulmonary Index Score (PIS), Pedi-
atric Asthma Severity Score (PASS), Childhood Asthma Score (CAS),
and the Pediatric Respiratory AssessmentMeasure (PRAM), only 6/59
(10.2%), 3/59 (5.1%), 1/59 (1.7%), and 0 (0%) of units always collected
the data required to calculate them.29 Therewere 6 severity scores for
which we could not identify any previous published validation; these
have been excluded from the analysis. Of the severity scores with a
validity score, the ASS score had the highest percentage of complete
collection among PERUKI sites. Both the PRAM and RAD severity
scorehad the lowestnumberofPERUKI sites collecting the full dataset;
however, these both scored high for validity score.
The survey also asked PERUKI centers about which factors they
would viewasmost important or useful in aPASS (seeSupporting Infor-
mation for full survey). These data are shown in Figure 2. Themost pri-
oritized features were “Score used accurately predicts safe discharge
from ED” (58/59) and “is fully validated in children” (57/59). The fea-
tures that were judged least useful by PERUKI centers were “used
in pediatric asthma papers published in high impact factor journals”
(40/59) and “Can be automatically generated by electronic patient
records” (40/59), although all options were still prioritized by more
than two out of three units (Figure 2).
4 LIMITATIONS
Theuseof a single responder in the survey could lead to responderbias,
because the environment that the responder worked in, their knowl-
edge of interpreting the parameters in children, and how they inter-
preted the questions being asked in the survey is unclear. In some
instances a responder may have answered the question from their
perception of what is captured or from first-hand knowledge of clini-
cal practice; unfortunately, this was not examined in the survey.
5 DISCUSSION
Accurate assessment of the severity of an asthma exacerbation is
important to aid clinical decision-making, audit, and research. This sys-
tematic reviewhighlights the considerable range of published pediatric
asthma severity scores that exist and how they all use combinations of
a common set of 15 parameters to generate their scores.
The optimal severity score to use when children and young people
attendwithanacuteexacerbationof asthmawill dependon several fac-
tors. Key areas that need to be considered include the use of the score
(safety of discharge, risk of PICU admission, something else), accuracy,
whether or not it is validated in children, and whether or not clinical
teams need additional training or resources to capture the required
parameters.
These questions require additional research to answer, and to date,
there has been little comparative research between the various pedi-
atric asthma severity scores. To facilitate this research, there will need
to be improvements in routine data collection. The majority of the
parameters required for existing asthma severity scores are already
included in the routine clinical assessment of a child with an asthma
attack. The variability is therefore likely to be in the recording these
data.Our survey shows that, currently, even if unitswished touse these
scores, they would not be able to derive them.
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F IGURE 2 Features of a pediatric asthma severity score prioritized by PERUKI sites
Electronic patient records may offer a way to improve this, because
there are options to have mandatory fields, to ensure the recording of
data, thereby generating large datasets wheremultiple severity scores
can be calculated and compared. Implementing patient pathways for
children’s asthma supported by electronic patient recordsmay be ben-
eficial, as it has helped deliver improvements in outcomes for other
conditions.30
For the vastmajority of the PERUKI respondentswho represent the
pediatric ED teams seeing children with acute asthma, it was a priority
that any severity score be validated in children. Validity in the pediatric
population has been considered previously but only included a sub-set
of the severity scores identified in this work.29
Training was identified as another important issue. Scalene muscle
retractionwas very poorly recorded in the survey, but is a requirement
in 2 of the severity scores.23,25 This parameter is dependent on pal-
pation, and to improve the use of this, there would be a considerable
investment in training required.
Although most of the children and young people who attend EDs
with acute asthma fully recover, around20 children a year in theUnited
Kingdom die from acute asthma attacks.31 There is a pressing need
to understand how to identify and optimally manage this population.
Improved data collection would only represent one aspect of this, but
if it were achieved, then the delivery of acute asthma research would
be simplified and research beyond the ED (eg, into the striking regional
variation in asthma attendances) would be facilitated.
6 CONCLUSION
Standardized PASS are infrequently used in the United Kingdom and
Ireland, although individual parameters are often collected by EDs.
Improved routine data collection focusing on the key parameters
common tomultiple scores could improve this, facilitating research and
audit of pediatric acute asthma.
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